Lung Toxicity of Carbon Nanotubes in Models of Pre-Existing Respiratory Disease

碳纳米管在已有呼吸系统疾病模型中的肺毒性

基本信息

项目摘要

DESCRIPTION (provided by applicant): Rapid advances in nanotechnology will be accompanied by the exposure of millions of individuals to products containing nanomaterials. Carbon Nanotubes (CNTs) are engineered nanomaterials designed for multiple uses (electronics, engineering, medicine), but have properties similar to asbestos, a fiber that is linked with the development of pulmonary fibrosis (tissue scarring) and mesothelioma (a rare cancer on the pleural surface of the lung). We recently reported that CNTs also exacerbate the development of allergic asthma in mice and increase pulmonary fibrosis in mice pre-exposed to bacterial lipopolysaccharide (LPS). Moreover, we found that mice which inhaled CNTs have increased platelet-derived growth factor (PDGF) and monocyte chemotactic protein-1 (MCP-1), two important mediators of fibrosis, asthma, and pleural disease. We also found that CNTs activate the tumor suppressor p53, which is implicated in mesothelioma. The overall goal of this proposal is to leverage existing in vitro and in vivo approaches to assess exposure and health effects of different types of carbon nanotubes that have modification of their surface chemistry through coating with various organic or inorganic agents. The specific hypothesis to be tested in this proposal is that inhaled CNTs pose a health risk by promoting immune and fibrotic reactions within the lung and pleura; particularly in individuals with pre-existing respiratory disease. The following specific aims will be carried out to test this hypothesis: In Aim 1, we will elucidate mechanisms through which inhaled CNTs exacerbate airway fibrosis in vivo using a well-established mouse model of allergic asthma and a well-established model of LPS-induced airway inflammation. In Aim 2, we will determine mechanisms through which inhaled CNTs cause immune and fibrotic reactions at the pleural surface of the lung, and whether CNT-induced pleural injury progresses to chronic fibrosis and/or neoplasia. In Aim 3, we will evaluate cell signaling pathways activated by CNTs in cultured macrophages, fibroblasts, and mesothelial cells that lead to the production of pro-fibrogenic cytokines and growth factors that play important roles in fibrosis, immune reactions, and cancer. This innovative and novel approach will provide valuable information on mechanisms through which carbon nanotubes cause fibrosis and pleural disease, and whether individuals with pre- existing respiratory disease such as asthma are at greater risk. Moreover, we will specifically modify the surface chemistry of carbon nanotubes to determine whether toxicity and disease susceptibility is increased or decreased. The new insights into the molecular mechanisms through which carbon nanotubes promote chronic lung disease will improve our understanding of the risk of these engineered nanomaterials and thereby fill a major knowledge gap. The broad impact of this work could directly affect the health and well-being of millions of people in a positive way by providing essential information for the design of safer nanomaterials. PUBLIC HEALTH RELEVANCE: The worldwide funding devoted to anotechnology research and development is expected to exceed $1 trillion by 2015. Carbon nanotubes are considered one of the most promising materials in nanotechnology and have numerous applications in medicine, industry and consumer products. For many of these applications, nanotubes will be coated with various organic or inorganic agents to modify their surface chemistry. The health risk of carbon nanotubes is unknown. However, their needle-like structure is reminiscent of asbestos fibers, which were exploited decades ago because of their superior insulating characteristics, but caused a worldwide pandemic of pleural lung cancer (mesothelioma) and pulmonary fibrosis. Human and environmental exposure to carbon nanotubes is inevitably increasing due to increased production for a variety of uses in electronics and structural engineering. Our most recent published data show that inhaled nanotubes significantly increase airway fibrosis associated with allergic asthma. Moreover, our recent unpublished findings show that inhaled nanotubes cause immune and fibrotic reactions on the pleural mesothelial surface in the lungs of mice. This alarming observation raises the possibility that carbon nanotubes could pose a serious threat to human health and the environment.
描述(由申请人提供):纳米技术的快速发展将伴随着数百万人接触含有纳米材料的产品。碳纳米管(CNT)是设计用于多种用途(电子,工程,医学)的工程纳米材料,但具有类似于石棉的特性,石棉是一种与肺纤维化(组织瘢痕)和间皮瘤(肺胸膜表面上的一种罕见癌症)的发展有关的纤维。我们最近报道,碳纳米管也加剧了小鼠过敏性哮喘的发展,并增加了预先暴露于细菌脂多糖(LPS)的小鼠肺纤维化。此外,我们发现吸入CNT的小鼠增加了血小板衍生生长因子(PDGF)和单核细胞趋化蛋白-1(MCP-1),这是纤维化、哮喘和胸膜疾病的两种重要介质。我们还发现,碳纳米管激活肿瘤抑制基因p53,这是在间皮瘤牵连。该提案的总体目标是利用现有的体外和体内方法来评估不同类型的碳纳米管的暴露和健康影响,这些碳纳米管通过涂覆各种有机或无机试剂对其表面化学进行了改性。本提案中待检验的具体假设是,吸入的CNT通过促进肺和胸膜内的免疫和纤维化反应而构成健康风险;特别是在先前存在呼吸道疾病的个体中。以下具体目标将进行测试这一假设:在目标1中,我们将阐明吸入的碳纳米管加剧气道纤维化在体内使用一个完善的小鼠模型过敏性哮喘和一个完善的模型LPS诱导的气道炎症。在目标2中,我们将确定吸入的CNT在肺胸膜表面引起免疫和纤维化反应的机制,以及CNT诱导的胸膜损伤是否进展为慢性纤维化和/或肿瘤。在目标3中,我们将评估CNT在培养的巨噬细胞、成纤维细胞和间皮细胞中激活的细胞信号传导途径,这些细胞信号传导途径导致促纤维化细胞因子和生长因子的产生,这些细胞因子和生长因子在纤维化、免疫反应和癌症中发挥重要作用。这种创新和新颖的方法将提供有关碳纳米管引起纤维化和胸膜疾病的机制的有价值的信息,以及预先存在哮喘等呼吸系统疾病的个体是否面临更大的风险。此外,我们将专门修改碳纳米管的表面化学,以确定毒性和疾病易感性是否增加或减少。对碳纳米管促进慢性肺部疾病的分子机制的新见解将提高我们对这些工程纳米材料风险的理解,从而填补一个主要的知识空白。这项工作的广泛影响可以通过为设计更安全的纳米材料提供必要的信息,以积极的方式直接影响数百万人的健康和福祉。 公共卫生相关性:到2015年,全球用于纳米技术研究和开发的资金预计将超过1万亿美元。碳纳米管被认为是纳米技术中最有前途的材料之一,在医学,工业和消费品中有许多应用。对于这些应用中的许多应用,纳米管将被涂覆各种有机或无机试剂以改变其表面化学。碳纳米管的健康风险是未知的。然而,它们的针状结构让人联想到石棉纤维,几十年前,石棉纤维因其上级绝缘特性而被开发,但却引起了胸膜肺癌(间皮瘤)和肺纤维化的全球大流行。由于电子和结构工程中各种用途的产量增加,人类和环境对碳纳米管的暴露不可避免地增加。我们最近发表的数据表明,吸入纳米管显著增加与过敏性哮喘相关的气道纤维化。此外,我们最近未发表的研究结果表明,吸入纳米管会导致小鼠肺部胸膜间皮表面的免疫和纤维化反应。这一令人担忧的观察结果提出了碳纳米管可能对人类健康和环境构成严重威胁的可能性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James Christopher Bonner其他文献

James Christopher Bonner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James Christopher Bonner', 18)}}的其他基金

Mechanisms of Nanoparticle Modulation of Allergic Lung Disease
纳米粒子调节过敏性肺病的机制
  • 批准号:
    10298297
  • 财政年份:
    2021
  • 资助金额:
    $ 54.05万
  • 项目类别:
Mechanisms of Nanoparticle Modulation of Allergic Lung Disease
纳米粒子调节过敏性肺病的机制
  • 批准号:
    10632116
  • 财政年份:
    2021
  • 资助金额:
    $ 54.05万
  • 项目类别:
Pilot Project Program
试点项目计划
  • 批准号:
    10403985
  • 财政年份:
    2015
  • 资助金额:
    $ 54.05万
  • 项目类别:
Pilot Project Program
试点项目计划
  • 批准号:
    10600030
  • 财政年份:
    2015
  • 资助金额:
    $ 54.05万
  • 项目类别:
Pilot Project Program
试点项目计划
  • 批准号:
    10162599
  • 财政年份:
    2015
  • 资助金额:
    $ 54.05万
  • 项目类别:
Genetic Susceptibility to Nanoparticle-Induced Respiratory Disease
纳米粒子诱发的呼吸道疾病的遗传易感性
  • 批准号:
    8686847
  • 财政年份:
    2012
  • 资助金额:
    $ 54.05万
  • 项目类别:
Genetic Susceptibility to Nanoparticle-Induced Respiratory Disease
纳米粒子诱发的呼吸道疾病的遗传易感性
  • 批准号:
    8850861
  • 财政年份:
    2012
  • 资助金额:
    $ 54.05万
  • 项目类别:
Genetic Susceptibility to Nanoparticle-Induced Respiratory Disease
纳米粒子诱发的呼吸道疾病的遗传易感性
  • 批准号:
    8371777
  • 财政年份:
    2012
  • 资助金额:
    $ 54.05万
  • 项目类别:
Genetic Susceptibility to Nanoparticle-Induced Respiratory Disease
纳米粒子诱发的呼吸道疾病的遗传易感性
  • 批准号:
    8538385
  • 财政年份:
    2012
  • 资助金额:
    $ 54.05万
  • 项目类别:
Genetic Susceptibility to Nanoparticle-Induced Respiratory Disease
纳米粒子诱发的呼吸道疾病的遗传易感性
  • 批准号:
    9084564
  • 财政年份:
    2012
  • 资助金额:
    $ 54.05万
  • 项目类别:

相似海外基金

A database construction of asbestos world flow for supply chain analysis: a multi-regional input-output approach
用于供应链分析的石棉世界流量数据库构建:多区域投入产出方法
  • 批准号:
    22K05940
  • 财政年份:
    2022
  • 资助金额:
    $ 54.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Comprehensive study on institutional design for Establishment of New Asbestos Health Damage Relief System
建立新型石棉健康损害救助体系的制度设计综合研究
  • 批准号:
    21K12369
  • 财政年份:
    2021
  • 资助金额:
    $ 54.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on asbestos release from weathered asbestos slate roofing materials during rainfall
降雨期间风化石棉板岩屋顶材料石棉释放的研究
  • 批准号:
    21K04331
  • 财政年份:
    2021
  • 资助金额:
    $ 54.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of in silico model for health impact assessment of Asbestos emitted from building materials
开发用于建筑材料排放石棉健康影响评估的计算机模型
  • 批准号:
    20KK0099
  • 财政年份:
    2020
  • 资助金额:
    $ 54.05万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
ALERT Real-Time Airborne Asbestos Detection
ALERT 实时机载石棉检测
  • 批准号:
    72508
  • 财政年份:
    2020
  • 资助金额:
    $ 54.05万
  • 项目类别:
    Feasibility Studies
Integrated automated asbestos fibre-counting and digital certification technology
集成自动化石棉纤维计数和数字认证技术
  • 批准号:
    73834
  • 财政年份:
    2020
  • 资助金额:
    $ 54.05万
  • 项目类别:
    Feasibility Studies
Integrated automated asbestos fibre-counting and digital certification technology
集成自动化石棉纤维计数和数字认证技术
  • 批准号:
    105739
  • 财政年份:
    2020
  • 资助金额:
    $ 54.05万
  • 项目类别:
    Study
ACME: Asbestos Containing Materials evaluation
ACME:含石棉材料评估
  • 批准号:
    85072
  • 财政年份:
    2020
  • 资助金额:
    $ 54.05万
  • 项目类别:
    Collaborative R&D
Commercial applications for treated material following denaturing of chrysotile asbestos
温石棉变性后处理材料的商业应用
  • 批准号:
    44543
  • 财政年份:
    2020
  • 资助金额:
    $ 54.05万
  • 项目类别:
    Study
Public policy research on asbestos disaster prevention centered on risk management
以风险管理为核心的石棉防灾公共政策研究
  • 批准号:
    20H04393
  • 财政年份:
    2020
  • 资助金额:
    $ 54.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了